Tami Tillotson Martin - Aug 4, 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. V.P., Regulatory Affairs
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Aug 4, 2022
Transactions value $
-$125,400
Form type
4
Date filed
8/5/2022, 04:31 PM
Previous filing
Feb 25, 2022
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $39.5K +5K +5.73% $7.90 92.2K Aug 4, 2022 Direct F1
transaction SUPN Common Stock Sale -$165K -5K -5.42% $32.98 87.2K Aug 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Options Exercise $0 -5K -50% $0.00 5K Aug 4, 2022 Common Stock 5K $7.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted May 19, 2022.
F2 The option vested in four equal annual installments beginning on February 5, 2014.